This miRNA physiologically downregulates thioredoxin-interacting protein (TXNIP), a physiological inhibitor of thioredoxin antioxidant activity, which is pathologically enhanced in diabetes and cardiovascular disease and involved in inflammation [93]. The gene discussed is TXNIP; the disease is diabetes mellitus.